Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:June 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:June 1, 2021Completed
Condition(s):Carcinoma, Squamous Cell of Head and NeckLast Updated:February 2, 2022Completed
Condition(s):Non-Small Cell Lung Cancer; Epidermal Growth Factor Receptor MutationLast Updated:April 19, 2023Recruiting
Condition(s):Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Multiple MyelomaLast Updated:November 8, 2023Active, not recruiting
Condition(s):Brain CancerLast Updated:March 10, 2022Completed
Condition(s):Distal Urethral Cancer; Proximal Urethral Cancer; Recurrent Bladder Cancer; Recurrent Urethral Cancer; Stage III Bladder Cancer; Stage III Urethral Cancer; Stage IV Bladder Cancer; Stage IV Urethral Cancer; Ureter CancerLast Updated:August 25, 2023Recruiting
Condition(s):Recurrent Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung CancerLast Updated:October 7, 2021Completed
Condition(s):ChordomaLast Updated:April 20, 2022Active, not recruiting
Condition(s):Advanced Squamous Non Small Cell Lung CancerLast Updated:October 19, 2023Recruiting
Condition(s):Non-squamous, Non-Small Cell Lung CancerLast Updated:October 31, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.